Developmental toxicity, which includes death, growth retardation, and structural or functional deficits (5), can be detected at any time during the lifespan of the organism as a result of perturbations) during gestation or after birth up to sexual maturity. Many times, there is an association between morphological defects or congenital malformations and functional alterations. Functional deficits include severe and mild mental retardation, cerebral palsy, psychoses, epilepsy and abnormal neurological development, learning and memory deficits, sensory dysfunction, changes in motor activity, and disrupted maturational milestones.
It has been estimated that about 20% of developmental defects are related to genetic causes, while another 10% appear to be associated with known exogenous factors such as drugs, infections, ionizing radiation, or environmental factors (6) . Thus, about 70% of developmental defects have no known cause. It is possible that some of these defects may be related to exposure to environmental agents or to a combination of genetic factors, nutritional deficiencies, drug abuse, tobacco, and/or therapeutic agents. Generally recognized human chemical developmental neurotoxicants include drugs of abuse (ethanol, cocaine, heroin, methadone), therapeutic agents (diphenylhydantoin), environmental agents (methylmercury, lead, polychlorinated biphenyls), and physical factors (X-ray) (7, 8) .
Regulation of Developmental Neurotoxicants
The possibility that developmental exposure to environmental agents might result in developmental neurotoxicity has led to promulgation of regulations and testing guidelines. Since 1975 , Japan and Great Britain have required behavioral testing in animal studies on new drugs (9) . Proposed testing guidelines for developmental neurotoxic effects of drugs and other chemicals have been published by the World Health Organization (WHO) (10) . Recently, the U.S. Environmental Protection Agency (U.S. EPA) published revised testing guidelines for developmental neurotoxicity assessments of toxic substances and pesticides (11) . U.S. EPA's testing guidelines provide direction for experimental design and dosing as well as information concerning the types of assessments that should be performed. Also Another criticism of routine testing for developmental neurotoxicity is that current testing guidelines rely heavily on behavioral assessments of sensory, motor, and cognitive function. Such tests are regarded by some as labor intensive, expensive to perform, and difficult to interpret (17) . Furthermore Dews (15) also expressed concern that the predictive value of rodent screens for developmental toxicants in humans has not been adequately demonstrated. The NRC report also acknowledged that extrapolation of toxicity data from adult and adolescent laboratory animals to young humans may be imprecise and careful attention to interspecies differences is necessary (14) . Dews (15) suggested that basic research on the mechanisms and control of development is needed before routine testing is required. Dews also suggested that assessment of developmental toxicity should be postponed until more is known about the mechanism of action of the chemical under investigation. Based on knowledge derived from such mechanistic studies, more appropriate and focused end points could be selected for subsequent developmental assessments.
To Test or Not to Test
There is concern that inappropriate toxicological assessments of chemicals using behavioral end points might unfairly impede the development of an otherwise useful therapeutic, industrial, or environmental agent (17) . Given the expense of such assessments and the potential loss of a useful product to society, such concerns must be considered. In this section, the points concerning the difficulties of developmental neurotoxicity testing raised by Dews (15) and Lochry (17) are discussed in greater detail. These areas of concern are that a) developing organisms are not especially vulnerable, b) developing organisms are resilient to perturbation, c) behavioral tests provide no advantage, d) maternal toxicity is a confounding variable, and e) poor predictive value. The objective of this discussion is to clarify important testing and data interpretation issues and emphasize certain concepts that underlie the application of behavioral testing in developmental studies.
Vulnerability ofDeveloping Organisms
Dews (15) asserted that it is not true that the developing nervous system is more sensitive to all aspects of the environment. As stated, Dews (15) is correct, i.e., the developing nervous system is not always more sensitive than the mature nervous system to environmental perturbation. A case in point is acrylamide, which produces a peripheral neuropathy in a wide range of species including humans (18) . Edwards (19) , however, found that acrylamide given to pregnant rats either in a single dose or in the diet had no adverse effect on the offspring, even at doses that produced neuropathy in the mothers. Acrylamide was found to pass the placental barrier, suggesting that the developing rat is not especially vulnerable to the toxic effects of acrylamide during the early period of growth and development. Although Agrawal and Squibb (20) 
Resilience of Developing Organisms
The second issue, raised by Dews (15) (24) dosed rats with triethyl tin (TET) on day 5 postpartum and assessed developmental neurotoxicity using behavioral tests for up to 90 days of age. Rats exposed to TET were hyperactive at 21, 28, and 60 days of age. However, TET-exposed animals tended to be hypoactive relative to controls at 90 days of age. One interpretation of these data is that the motor deficit seen at earlier ages was not permanent and that adult animals exposed developmentally to TET had recovered. In a subsequent experiment, however, Harry and Tilson (25) challenged adult rats exposed to TET developmentally with apomorphine, a chemical that stimulates motor activity by activating dopamine receptors directly, and found that TET-exposed animals were significantly more sensitive to the stimulant effects of apomorphine than controls. Subsequent neurochemical experiments found a persistent change in dopamine binding in the striatum of TET-exposed animals. These studies indicate that apparent recovery of function that occurs with age should be interpreted cautiously in developmental studies. Longterm, persistent deficits in nervous system function cannot be ruled out in studies where apparent recovery is observed.
Another point that should be considered is that developmental exposure to neurotoxicants might interact with the aging process. Barone and colleagues (26) exposed rats to triethyl tin and found that the effects on learning in younger animals were exacerbated as the animals aged. In this study, rats dosed with triethyl tin showed marginal deficits at 3 months of age, no deficits at 12 months of age, and significant cognitive impairment relative to age-matched controls at 24 months of age. Delayed onset neurotoxicity has also been reported in monkeys exposed developmentally to methylmercury (27) .
Advantage of Traditional Behavioral Tests
Lochry (17) argued that the behavioral measures used in developmental neurotoxicity studies are not more sensitive than other, more traditional indicators of toxicity. Faber and O'Donoghue (28), for example, identified 41 developmental neurotoxicants from Shepard's catalogue of teratogenic agents (4) and found that 37 showed positive effects in the Chernoff/ Kavlock assay, which measures the number of pups per litter, the birth weight, and viability of pups up to 3 or 4 days postnatally. These findings suggested that the Chernoff/Kavlock assay may be sufficient to detect potential developmental neurotoxicants and that more costly behavioral tests may not be necessary for screening. In a followup to the Faber and O'Donoghue report, Goldey et al. (29) evaluated studies in which 126 compounds were assessed for developmental neurotoxicity. Studies in which all or part of the Chernoff/Kavlock screen had been used and behavioral testing had been performed on the same compound were selected for further analysis. Goldey et al. (29) found that of the 126 agents evaluated, 110 were found to be developmental neurotoxicants using behavioral tests. Of those 1 10 compounds, 72 had been tested on one of the measures in the Chernoff/Kavlock assay; more than a third of them had been found to be negative. The developmental neurotoxicants that were negative in the Chernoff/Kavlock assay included several drugs, food additives, and solvents. These observations indicate that behavioral tests afford a level of sensitivity needed in developmental neurotoxicology studies.
Lochry (17) incomplete or missing information concerning the actual internal dose relative to the administered dose, and insufficient information concerning the most sensitive end points. One conclusion from developmental neurotoxicity studies using animal models is that the degree of cross-species comparability is facilitated by close attention to using end points for which there are comparable developmental profiles and common underlying neural substrates. Good quantitative comparisons between animal models and humans will be improved following development of mathematical and physiologically based dose-response models.
Summary and Conclusions
The area of developmental neurotoxicology has evolved rapidly over the last several years. Initially it was shown that developmental exposure to environmental agents can affect behavioral measures in the offspring. Subsequent experiments have confirmed that the developing organism is sensitive to a wide range of chemical factors. The potential threat of developmental neurotoxicity following exposure to chemicals has led to the promulgation of regulatory guidelines for the preapproval of chemicals. The potential expense of such tests, however, has elicited concerns about the general sensitivity of the developing organism, sensitivity of functional tests, and interpretation of data generated in behavioral developmental studies.
Research, however, has shown that the developing organism can be highly sensitive to a wide range of environmental factors if exposure occurs at a critical period of nervous system development. Furthermore, standardized behavioral tests are now available to assess the developmental neurotoxicity of chemicals and such tests have been successful in detecting and quantifying the effects of human developmental neurotoxicants in animal models.
Concerns about the cost effectiveness of developmental neurotoxicity studies have been raised in recent years. Advances in developmental neurobiology and experience with standardized testing protocols in neurotoxicology, however, suggest that welldesigned studies selecting appropriate behavioral tests can provide useful information about potential neurotoxicity of chemical agents. In addition, behavioral measures in conjunction with appropriate neurochemical and anatomical end points can be used to address hypothesis-driven questions concerning the site and mechanism of action of developmental neurotoxicants.
